Southern blot analyses of surgical specimens of cervical carcinoma from Japanese patients showed that 3/9 samples contained human papillomavirus (HPV) type-I6 DNA sequences, and 2 contained HPV type-I6 DNA sequences. By Northern blot analyses, RNA transcripts of HPV DNA sequences were demonstrated i
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
✍ Scribed by Adriana Aguilar-Lemarroy; Sabine Kirchhoff; Noel Whitaker; Patricio Gariglio; Harald zur Hausen; Peter H. Krammer; Frank Rösl
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 343 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1405
No coin nor oath required. For personal study only.
✦ Synopsis
When cervical carcinoma cells were monitored for apoptotic signals, HPV18 ؉ lines were found to be highly sensitive to agonistic CD95 antibodies or recombinant CD95 ligands after co-exposure with CHX (CD95 S ). In contrast, HPV16 ؉ cervical carcinoma cells and HPV16-immortalized non-malignant human keratinocytes were CD95-resistant (CD95 R ) under equivalent conditions. Somatic cell hybridization between CD95 S and CD95 R cervical carcinoma cell lines revealed that CD95 sensitivity was a dominant trait, which could be correlated with abundant c-Myc and low Bcl-X L expression. Although CD95 R cervical carcinoma cells expressed even higher levels of p53 and CD95 receptor at the surface, resistance could be attributed to the inability to form a functional DISC, necessary for successful transmission of the apoptogenic response. These data indicate that resistance to apoptotic stimuli represents an important immunological escape mechanism during virus-induced carcinogenesis.
📜 SIMILAR VOLUMES
Certain human papillomaviruses (HPV), mainly types 16 and 18, have been widely recognized as an essential etiologic factor for the development of carcinoma of the uterine cervix. The early HPV proteins E6 and E7 are consistently expressed in the tumor cells, and cervical-carcinoma patients can devel
## Abstract CD4^+^CD25^hi^CTLA4^+^FoxP3^+^ regulatory T cells (Treg) have been shown to maintain immune tolerance against self antigens and increased circulating frequencies have been reported in various types of cancers. Circulating invariant natural killer T‐cells (iNKT) are reduced in cancer pat